SANTIC; Radmila

Patent Applications and Registrations

Patent applications and USPTO patent grants for SANTIC; Radmila.The latest application filed is for "mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders".

Company Profile

2.7.5

SANTIC; Radmila - Vienna AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mimotopes Of Alpha-synuclein And Vaccines Thereof For The Treatment Of Neurodegenerative Disorders App 20200254076 - Kind Code	2020-08-13
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders Grant 10,517,935 - Mandler , et al. Dec	2019-12-31
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders Grant 9,724,399 - Mandler , et al. August 8, 2	2017-08-08
Mimotopes Of Alpha-synuclein And Vaccines Thereof For The Treatment Of Neurodegenerative Disorders App 20170158744 - MANDLER; Markus ; et al.	2017-06-08
Means for treating synucleinopathies Grant 8,828,942 - Mandler , et al. September 9, 2	2014-09-09
Compounds for treating amyloidoses Grant 8,409,581 - Mandler , et al. April 2, 2	2013-04-02
Means For Treating Synucleinopathies App 20120156234 - Mandler; Markus ; et al.	2012-06-21
Compounds For Treating Amyloidoses App 20110171243 - Mandler; Markus ; et al.	2011-07-14
Mimotopes Of Alpha-synuclein And Vaccines Thereof For The Treatment Of Neurodegenerative Disorders App 20110092434 - Mandler; Markus ; et al.	2011-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.